- Home
- Life Sciences
- Pharmaceutical
- Pathology
- Pathology Analysis & Statistics, April 2013 (p5)
Talk to Alison
00 1 718 618 48 97
Search inside this page
Top countries
- United States (3 964)
- World (47 560)
- Japan (2 638)
- France (2 545)
- Germany (2 536)
-
- Spain (2 520)
- United Kingdom (2 502)
- Europe (548)
- Italy (2 531)
- China (2 438)
- India (2 392)
- Canada (2 196)
- Australia (2 157)
- Sweden (2 019)
- Denmark (2 010)
- South Korea (2 355)
- Norway (2 006)
- Singapore (2 167)
- Switzerland (2 053)
- Indonesia (2 294)
Publication dates
Publishers
- Global Data (1 525)
- Global Markets Direct (1 838)
- Bioseeker (243)
- Euromonitor International (26)
- BCC Research (41)
-
- Ibisworld (8)
- Daedal Research (2)
- Firstword Pharma (7)
- GBI Research (41)
- KnowMade (2)
- World Market Intelligence Ltd (18)
- Asianet-Pakistan (4)
- Currentpartnering (97)
- Global Industry Analysts (1)
- International Market Analysis Research and Consult (11)
- La Merie Publishing (31)
- MarketLine (41)
- Transparency Market Research (1)
- TriMark Publications (7)
- Business Monitor International (401 825)
- Datamonitor (316)
- Life Science Analytics (LSA) (61)
- Global Research & Data Services (55)
- ICD Research (47)
- Frost & Sullivan (44)
- Timely Data Resources Inc. (41)
- Visiongain (32)
- Global Industry Analyst (28)
- Espicom Business Intelligence (27)
- Business Review (23)
- ABMRG (22)
- The Assessment Group (19)
- Kalorama Information (17)
- SCRIP Insights (17)
- Koncept Analytics (15)
- Asia Market Information & Development Company (14)
- CHI Insight Pharma Reports (14)
- Apollo Managed Care Consultants (13)
- Infiniti Research Limited (9)
- Sociable Pharma (9)
- IData Research, Inc. (9)
- Grey House Publishing (7)
- RNCOS (6)
- BioPharm Reports (5)
- MarketsandMarkets (5)
- Venture Planning Group (5)
- Aruvian's R'search (4)
- Freedonia (4)
- Canadean Ltd (3)
- Netscribes (India) Pvt. Ltd. (3)
- Renub Research (3)
- Arrowhead (2)
- France Innovation Scientifique et Transfert (2)
- Greystone Research Associates (2)
- Packaged Facts (2)
- Urch Publishing (2)
- Barnes Reports (1)
- Cygnus Business Consulting and Research (1)
- Ken Research Private (1)
- PMR Ltd. (1)
- Red Mountain Insights (1)
- Research In China (1)
- VacZine Analytics Group Of Assay Advantage Ltd (1)
- Verdict Research Ltd (1)
- WinterGreen Research (1)
- Zzz FACT Research (1)
All regions
-
- Algeria (2 248)
- Angola (2 320)
- Benin (2 312)
- Botswana (2 225)
- Burkina Faso (2 294)
- Burundi (2 306)
- Cameroon (2 318)
- Cape Verde (2 243)
- Central African Republic (106)
- Chad (2 313)
- Comoros (2 099)
- Congo, Democratic Republic Of (2 505)
- Djibouti (2 289)
- Egypt (2 338)
- Equatorial Guinea (2 292)
- Eritrea (2 259)
- Ethiopia (2 297)
- Gabon (2 269)
- Gambia (2 277)
- Ghana (2 321)
- Guinea (6 871)
- Guinea Bissau (2 303)
- Kenya (2 294)
- Lesotho (2 130)
- Liberia (2 210)
- Libyan Arab Jamahiriya (2 235)
- Madagascar (2 268)
- Malawi (2 309)
- Mali (2 318)
- Mauritania (2 262)
- Mauritius (2 206)
- Morocco (2 311)
- Mozambique (2 290)
- Namibia (2 221)
- Niger (2 318)
- Nigeria (2 327)
- Rwanda (2 281)
- Sao Tome and Principe (1 956)
- Senegal (2 315)
- Seychelles (2 063)
- Sierra Leone (2 307)
- Somalia (2 231)
- South Africa (2 267)
- Sudan (2 336)
- Swaziland (2 206)
- Tanzania (2 290)
- Togo (2 309)
- Tunisia (2 237)
- Uganda (2 320)
- Zambia (2 289)
- Zimbabwe (2 288)
-
- Afghanistan (2 321)
- Armenia (2 178)
- Azerbaijan (2 186)
- Bahrain (2 030)
- Bangladesh (2 288)
- Bhutan (2 207)
- Brunei Darussalam (2 078)
- Cambodia (2 300)
- China (2 438)
- Georgia (2 084)
- India (2 392)
- Indonesia (2 294)
- Iran (2 223)
- Iraq (2 315)
- Israel (2 034)
- Japan (2 638)
- Jordan (2 146)
- Kazakhstan (2 118)
- Kuwait (2 116)
- Kyrgyz Republic (kyrgyzstan) (2 187)
- Laos (2 295)
- Lebanon (1 553)
- Malaysia (2 290)
- Maldives (2 199)
- Mongolia (99)
- Myanmar (2 260)
- Nepal (2 280)
- North Korea (119)
- Oman (2 189)
- Pakistan (2 300)
- Philippines (2 300)
- Qatar (2 012)
- Saudi Arabia (2 234)
- Singapore (2 167)
- South Korea (2 355)
- Sri Lanka (2 254)
- Syrian Arab Republic (2 188)
- Taiwan (19)
- Tajikistan (2 163)
- Thailand (2 292)
- Turkey (5)
- Turkmenistan (98)
- United Arab Emirates (2 142)
- Uzbekistan (2 189)
- Vietnam (2 311)
- Yemen (2 334)
-
- Albania (2 040)
- Andorra (1 425)
- Austria (2 030)
- Belarus (2 055)
- Belgium (2 052)
- Bosnia and Herzegovina (2 028)
- Bulgaria (2 053)
- Croatia (2 006)
- Cyprus (1 986)
- Czech Republic (2 008)
- Denmark (2 010)
- Estonia (1 966)
- Finland (1 993)
- France (2 545)
- Germany (2 536)
- Greece (2 087)
- Hungary (2 039)
- Iceland (1 904)
- Ireland (2 032)
- Italy (2 531)
- Latvia (2 017)
- Lithuania (2 087)
- Luxembourg (1 932)
- Macedonia (91)
- Malta (1 990)
- Moldova, Republic Of (2 023)
- Monaco (1 268)
- Netherlands (2 052)
- Norway (2 006)
- Poland (2 080)
- Portugal (2 110)
- Romania (2 068)
- Russian Federation (2 148)
- San Marino (1 114)
- Serbia and Montenegro (2 060)
- Slovakia (slovak Republic) (2 045)
- Slovenia (1 978)
- Spain (2 520)
- Sweden (2 019)
- Switzerland (2 053)
- Ukraine (2 096)
- United Kingdom (2 502)
-
- Antigua and Barbuda (2 061)
- Bahamas (2 105)
- Barbados (2 101)
- Belize (2 122)
- Canada (2 196)
- Costa Rica (2 185)
- Cuba (2 211)
- Dominica (4 113)
- Dominican Republic (2 285)
- El Salvador (2 220)
- Grenada (2 018)
- Guatemala (2 373)
- Haiti (2 275)
- Honduras (2 317)
- Jamaica (2 169)
- Mexico (2 379)
- Nicaragua (2 265)
- Panama (1 561)
- Saint Kitts & Nevis (1 889)
- Saint Lucia (2 227)
- United States (3 964)
-
- Argentina (2 263)
- Australia (2 157)
- Brazil (2 439)
- Canada (2 196)
- China (2 438)
- France (2 545)
- Germany (2 536)
- India (2 392)
- Indonesia (2 294)
- Italy (2 531)
- Japan (2 638)
- Mexico (2 379)
- Russian Federation (2 148)
- Saudi Arabia (2 234)
- South Africa (2 267)
- South Korea (2 355)
- Turkey (5)
- United Kingdom (2 502)
- United States (3 964)
-
- Australia (2 157)
- Austria (2 030)
- Belgium (2 052)
- Canada (2 196)
- Chile (2 214)
- Czech Republic (2 008)
- Denmark (2 010)
- Estonia (1 966)
- Finland (1 993)
- France (2 545)
- Germany (2 536)
- Greece (2 087)
- Hungary (2 039)
- Iceland (1 904)
- Ireland (2 032)
- Israel (2 034)
- Italy (2 531)
- Japan (2 638)
- Luxembourg (1 932)
- Mexico (2 379)
- Netherlands (2 052)
- New Zealand (1 942)
- Norway (2 006)
- Poland (2 080)
- Portugal (2 110)
- Slovenia (1 978)
- South Korea (2 355)
- Spain (2 520)
- Sweden (2 019)
- Switzerland (2 053)
- Turkey (5)
- United Kingdom (2 502)
- United States (3 964)
data types
Free Market Research Guides to Download
Pathology Analysis & Statistics, April 2013 (p5)
You might be interested in: cancer, breast cancer, prostate cancer, more »
» Purchase Premium Reports
121-160 of about 4 800 reports
World Pathology: Cystic Fibrosis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Cystic Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World
World Pathology: Systemic Sclerosis (Scleroderma) ? Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
- Industries : Pathology
- Countries : World, United States
Pathology in Japan: Pruritus - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Pruritus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...
- Industries : Pathology
- Countries : Japan, United States, World
Biological Therapy in United States: T-Cell Lymphomas - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for T-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : United States
Pathology Industry: Sickle Cell Disease - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Sickle Cell Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : United States, World
World Drug and Medication: Bile Duct Cancer (Cholangiocarcinoma) ? Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Bile Duct Cancer (Cholangiocarcinoma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
- Industries : Pathology
- Countries : World
World Pathology: Polycystic Kidney Disease - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Polycystic Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
World Pathology: Bronchiectasis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Bronchiectasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : United States, World, Germany
Pathology Industry: Schizophrenia - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Schizophrenia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : United States
Perennial Allergic Rhinitis - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Perennial Allergic Rhinitis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Perennial Allergic Rhinitis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...
- Industries : Pathology
- Countries : World, United States
Other Hematological Disorders - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Other Hematological Disorders - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Other Hematological Disorders - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...
- Industries : Pathology
- Countries : Japan, World
Pathology in United States: Non-Hodgkin Lymphoma - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Non-Hodgkin Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : United States
World Pathology: Female Sexual Dysfunction - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Female Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
Lung Disease - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Lung Disease - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Lung Disease - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Pathology
- Countries : World
Pathology Industry: Traumatic Brain Injury - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Traumatic Brain Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013', provides an overview of the indication's ...
- Industries : Pathology
World Pathology: Athlete%s Foot (Tinea Pedis) ? Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
Athlete's Foot (Tinea Pedis) ? Pipeline Review, H1 2012 What's inside this report? Global Industries Direct's, 'Athlete's Foot (Tinea Pedis) - Pipeline Review, H1 2012', provides an overview of the ...
- Industries : Pathology
- Countries : World
Cardiomyopathy - Pipeline Review, H1 2013
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
Cardiomyopathy - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Cardiomyopathy - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Pathology
- Countries : World, United States
World Drug and Medication: Burkitt Lymphoma - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Burkitt Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World
Therapy Industry: Glioma - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013', provides an overview of the indication's ...
- Industries : Pathology
- Countries : World
World Pathology: Friedreich Ataxia - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Friedreich Ataxia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World, United States
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2013
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2013', provides an overview of the ...
- Industries : Pathology
- Countries : United States
Secondary Hyperparathyroidism - Pipeline Review, H1 2013
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
Secondary Hyperparathyroidism - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Secondary Hyperparathyroidism - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...
- Industries : Pathology
- Countries : World, United States
Pathology Industry: Lung Cancer - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013', provides an overview of the ...
- Industries : Pathology
- Countries : World
Pathology Industry: Inflammatory Bowel Disease - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Inflammatory Bowel Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
- Industries : Pathology
Pathology in United States: Acute Renal Failure (ARF) (Acute Kidney Injury) ? Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with latest updates, and special features on late-stage and discontinued projects. ...
- Industries : Pathology
- Countries : United States, World
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2013
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2013', provides an overview of the ...
- Industries : Pathology
Pathology Industry: Squamous Cell Carcinoma - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Squamous Cell Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
Austria Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Austria
Norway Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Norway
Palau Post-traumatic Stress Disorder, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : World
Lesotho Post-traumatic Stress Disorder, 15-29 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Lesotho
Iraq Prostate Cancer, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Iraq, World
Paraguay Prostate Cancer, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Paraguay
Papua New Guinea Schistosomiasis, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Papua New Guinea, Guinea
Honduras Prostate Cancer, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Honduras
Dominican Republic Post-traumatic Stress Disorder, 30-44 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Dominican Republic, Dominica
Belgium Protein-energy Malnutrition, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Belgium
» Download Public Reports
About 17 000 reports
Company Report: Pathology in The United States and Ireland for Year 2013
- Company report
- May 2013
- 5 pages
- by Corporation
... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...
Pharmaceutical Business Analysis
May 2013U.s. Pharmaceutical Industry
May 2013The Swazi Pharmaceutical Industry
May 2013» Read our Company Profiles
About 200 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandGlaxoSmithKline PLC
United KingdomEli Lilly and Co.
United StatesLilly and Co.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
